NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

I agree with your analysis. This is exactly whats going to happen without significant non dilutive funding. They don’t even have money to expand their team for UK commercial launch. Companies big or small hire and train staff 6 months in advance.

How can they do any justice to another set of clinical trials without significant funding and dilution?

Forget about tissue agnostic label for another 10-15 years at best! And that too a ton of uncertainty in terms of proving that! ;)

Flaskworks is not getting approved for commercial production until 2027 at the earliest. LP indicated that they don’t have funding to make further progress on this front either. Plus there is a ton of uncertainty in terms of validation for them to deliver on 2027 promise too.